Vice President, Chemistry, Manufacturing and Controls (CMC)

Contact: Todd Rosengarten
Phone: (267) 948-1436

Position Overview

Our client is a well-financed, venture-backed clinical-stage biotechnology company built around a platform designed to improve upon existing therapeutic agents in a large, validated disease area. The company’s discovery and early development work is led by an experienced protein engineering and company-building team with a strong track record of advancing programs into the clinic and building successful biotech companies.

They are seeking Vice President of CMC to lead end-to-end chemistry, manufacturing and controls strategy for the company’s lead program and pipeline as it advances toward IND-enabling and first-in-human milestones. This is a critical, value-defining role with full accountability for drug substance, drug product (formulation), analytical, QC, device, and the company’s external manufacturing network.

Key Responsibilities:

CMC Strategy and Leadership

  • Own CMC strategy across drug substance, drug product (formulation), analytical, QC, and device development
  • Align CMC plans with clinical, regulatory, and corporate milestones, including upcoming regulatory filings to support first-in-human studies
  • Build and execute the CMC roadmap supporting healthy volunteer data and early clinical proof-of-concept data

Technology Transfer and Manufacturing Oversight

  • Lead drug substance and drug product process and analytical technology transfer across external partners
  • Oversee process development, scale-up, and clinical manufacturing through IND-enabling and early clinical stages
  • Ensure continuity of supply and manufacturing robustness across the network
  • Direct device and drug product integration for combination product strategy

External Manufacturing Network Management

  • Build and manage the company’s fully outsourced CMC network across drug substance, drug product, analytical, and device workstreams
  • Establish governance, performance metrics, and risk mitigation across CDMO relationships
  • Negotiate and manage key vendor and CDMO relationships, including technology transfer and capacity planning

Quality and Regulatory Interface

  • Partner with Quality and Regulatory functions to ensure compliance and inspection readiness across the CDMO network
  • Own CMC sections of regulatory filings supporting first-in-human and subsequent clinical studies
  • Lead responses to regulatory questions related to CMC

Organizational Build-Out

  • Build and scale the CMC/Technical Operations function as the company grows
  • Hire and develop internal talent while leveraging external expertise and CDMO partners
  • Establish systems, processes, and infrastructure appropriate for a lean, outsourced operating model

Key Requirements:

  • 15+ years in biologics CMC, with progressive leadership across drug substance, drug product, analytical, QC, and/or device functions
  • Prior leadership role with end-to-end CMC accountability
  • Experience advancing biologic programs from preclinical through IND filing; experience through late stage/BLA is a plus.
  • Deep experience managing external CDMO networks in a fully outsourced model
  • Hands-on experience with technology transfer and process validation
  • Experience with devices and combination products preferred but not required
  • Proven ability to operate in lean, high-impact environments with limited internal infrastructure
  • Strong execution mindset with the ability to manage complex, parallel workstreams
  • Strong written and oral communicator, credible in front of board members and investors
  • Builder mentality, comfortable establishing a function rather than only operating within one

Location(s)

Waltham, MA

If interested, please send a MS Word version of your resume to [email protected]

Submit Your Résumé